Literature DB >> 6261250

Reversible growth arrest in simian virus 40-transformed human fibroblasts.

R M Hoffman, S J Jacobsen.   

Abstract

A reversible growth arrest of simian virus 40-transformed human fibroblasts has been produced by replacement of methionine in the growth medium by its immediate metabolic precursor, homocysteine, Although these arrested cells exhibit a greatly reduced cloning efficiency when plated in methionine-supplemented medium, they resume rapid proliferation without a lag when subconfluent cells are refed with methionine-supplemented medium. This growth arrest is accompanied by a reduction in the percentage of mitotic cells in the cell population. Furthermore, data obtained using fluorescence-activated cell sorting techniques indicate that the cells are arrested i the S and G2 phases of the cell cycle. This is in contrast to a G1-phase accumulation of cells, which occurs only in methionine-supplemented medium at very high densities and which is similar to the G1 block seen in cultures of normal fibroblasts at high density. The apparent relationship between specific events in the DNA-synthetic and premitotic phase of the cell cycle and methionine dependence in these transformed cultures is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6261250      PMCID: PMC350491          DOI: 10.1073/pnas.77.12.7306

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Arrest of cultured rat liver cells in G2 phase by the treatment with dibutyryl cAMP.

Authors:  K Nose; H Katsuta
Journal:  Biochem Biophys Res Commun       Date:  1975-01-02       Impact factor: 3.575

2.  Selective killing of transformed baby hamster kidney (BHK) cells.

Authors:  A B Pardee; L J James
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Resting state in normal and simian virus 40 transformed Chinese hamster lung cells.

Authors:  R G Martin; S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  5-methyltetrahydrofolate: synthesis and utilization in normal and SV40-transformed BHK-21 cells.

Authors:  S J Jacobsen; J A North; N A Rao; J H Mangum
Journal:  Biochem Biophys Res Commun       Date:  1977-05-09       Impact factor: 3.575

5.  Mechanism of growth arrest of chemically transformed cells in culture.

Authors:  H L Moses; J A Proper; M E Volkenant; D J Wells; M J Getz
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

6.  Interference with S and G2 phase progression by polyamine synthesis inhibitors.

Authors:  O Heby; G Andersson; J W Gray
Journal:  Exp Cell Res       Date:  1978-02       Impact factor: 3.905

7.  Tumor viruses: 1974.

Authors:  D Baltimore
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

8.  High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine.

Authors:  R M Hoffman; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

9.  Simian virus 40-host cell interaction during lytic infection.

Authors:  E L Gershey
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

10.  Regulation of 5-methyltetrahydrofolate: homocysteine methyltransferase activity by methionine, vitamin B12, and folate in cultured baby hamster kidney cells.

Authors:  D Kamely; J W Littlefield; R W Erbe
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

View more
  42 in total

1.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

2.  Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

3.  Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.

Authors:  Yanchun Wang; Zhongguang Luo; Yongfu Pan; Weige Wang; Xiaoyan Zhou; Lak Shin Jeong; Yiwei Chu; Jie Liu; Lijun Jia
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 4.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

5.  Unchecked DNA synthesis and blocked cell division induced by methionine deprivation in a human prostate cancer cell line.

Authors:  H Y Guo; R M Hoffman; H Herrera
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

6.  Growth inhibitory and stimulatory effects of retinoic acid on murine 3T3 cells.

Authors:  E W Schroder; E Rapaport; A K Kabcenell; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Shukuan Li; Qinghong Han; Yuying Tan; Ming Zhao; Yunfeng Li; Scott D Nelson; Sarah M Dry; Arun S Singh; Irmina A Elliott; Tara A Russell; Mark A Eckardt; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

8.  De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

Authors:  Everett Stone; Olga Paley; Jian Hu; Barbara Ekerdt; Nai-Kong Cheung; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-09-21       Impact factor: 5.100

9.  Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.

Authors:  Jian Hu; Nai-Kong V Cheung
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

10.  Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells.

Authors:  D W Coalson; J O Mecham; P H Stern; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.